|
2025-02-04 |
2025-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
1 896
-1.3%
11,14
21 121 USD
|
1 896
-1.3%
|
11,14
|
21 121 USD
|
|
|
2025-02-04 |
2025-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
1 896
-1.3%
11,14
21 121 USD
|
1 896
-1.3%
|
11,14
|
21 121 USD
|
|
|
2025-02-04 |
2025-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
759
-0.5%
11,14
8 455 USD
|
759
-0.5%
|
11,14
|
8 455 USD
|
|
|
2025-02-04 |
2025-01-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
2 767
-7.8%
11,14
30 824 USD
|
2 767
-7.8%
|
11,14
|
30 824 USD
|
|
|
2025-02-04 |
2025-01-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
3 354
-10.1%
11,14
37 364 USD
|
3 354
-10.1%
|
11,14
|
37 364 USD
|
|
|
2025-02-04 |
2025-01-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
1 258
-4.5%
11,14
14 014 USD
|
1 258
-4.5%
|
11,14
|
14 014 USD
|
|
|
2024-09-12 |
2024-09-09 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
1 521
-5.7%
13,08
19 895 USD
|
1 521
-5.7%
|
13,08
|
19 895 USD
|
|
|
2024-09-12 |
2024-09-09 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
859
-0.6%
13,08
11 236 USD
|
859
-0.6%
|
13,08
|
11 236 USD
|
|
|
2024-06-11 |
2024-06-10 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
5 153
-3.4%
13,08
67 401 USD
|
5 153
-3.4%
|
13,08
|
67 401 USD
|
|
|
2024-03-20 |
2024-03-18 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
12 000
-7.9%
14,05
168 600 USD
|
12 000
-7.9%
|
14,05
|
168 600 USD
|
|
|
2024-02-02 |
2024-01-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
3 328
-12.4%
15,74
52 383 USD
|
3 328
-12.4%
|
15,74
|
52 383 USD
|
|
|
2024-02-02 |
2024-01-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
1 248
-5.9%
15,74
19 644 USD
|
1 248
-5.9%
|
15,74
|
19 644 USD
|
|
|
2024-02-02 |
2024-01-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
417
-2.2%
15,74
6 564 USD
|
417
-2.2%
|
15,74
|
6 564 USD
|
|
|
2024-02-02 |
2024-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
1 894
-1.2%
15,74
29 812 USD
|
1 894
-1.2%
|
15,74
|
29 812 USD
|
|
|
2024-02-02 |
2024-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
758
-0.5%
15,74
11 931 USD
|
758
-0.5%
|
15,74
|
11 931 USD
|
|
|
2024-02-02 |
2024-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
1 137
-0.8%
15,74
17 896 USD
|
1 137
-0.8%
|
15,74
|
17 896 USD
|
|
|
2023-09-05 |
2023-08-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
3 800
-17.1%
18,01
68 438 USD
|
3 800
-17.1%
|
18,01
|
68 438 USD
|
|
|
2023-02-02 |
2023-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
661
-0.4%
10,12
6 689 USD
|
661
-0.4%
|
10,12
|
6 689 USD
|
|
|
2023-02-02 |
2023-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
991
-0.7%
10,12
10 029 USD
|
991
-0.7%
|
10,12
|
10 029 USD
|
|
|
2023-02-02 |
2023-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
248
-0.2%
10,12
2 510 USD
|
248
-0.2%
|
10,12
|
2 510 USD
|
|
|
2023-02-02 |
2023-01-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
1 227
-8.1%
10,12
12 417 USD
|
1 227
-8.1%
|
10,12
|
12 417 USD
|
|
|
2023-02-02 |
2023-01-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
409
-3.1%
10,12
4 139 USD
|
409
-3.1%
|
10,12
|
4 139 USD
|
|
|
2022-11-02 |
2022-10-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
258
-1.1%
11,85
3 057 USD
|
258
-1.1%
|
11,85
|
3 057 USD
|
|
|
2022-09-02 |
2022-08-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
3 606
-22.8%
7,21
25 999 USD
|
3 606
-22.8%
|
7,21
|
25 999 USD
|
|
|
2022-08-25 |
2022-08-01 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
259
-1.1%
7,81
2 023 USD
|
259
-1.1%
|
7,81
|
2 023 USD
|
|
|
2022-05-03 |
2022-04-30 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
254
-1.1%
6,62
1 681 USD
|
254
-1.1%
|
6,62
|
1 681 USD
|
|
|
2022-02-02 |
2022-01-31 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
414
-5.3%
7,58
3 138 USD
|
414
-5.3%
|
7,58
|
3 138 USD
|
|
|
2022-02-02 |
2022-01-31 |
V
Vente
|
Barrett Elizabeth A.
Chief Executive Officer
Dirigeant
|
5 960
-1.9%
7,58
45 177 USD
|
5 960
-1.9%
|
7,58
|
45 177 USD
|
|
|
2022-02-02 |
2022-01-31 |
V
Vente
|
Barrett Elizabeth A.
Chief Executive Officer
Dirigeant
|
2 235
-0.7%
7,58
16 941 USD
|
2 235
-0.7%
|
7,58
|
16 941 USD
|
|
|
2022-02-02 |
2022-01-31 |
V
Vente
|
Henderson Molly
Chief Financial Officer
Dirigeant
|
331
-5.9%
7,58
2 509 USD
|
331
-5.9%
|
7,58
|
2 509 USD
|
|
|
2022-02-02 |
2022-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
1 099
-4.5%
7,58
8 330 USD
|
1 099
-4.5%
|
7,58
|
8 330 USD
|
|
|
2022-02-02 |
2022-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
275
-1.2%
7,58
2 085 USD
|
275
-1.2%
|
7,58
|
2 085 USD
|
|
|
2022-01-28 |
2022-01-26 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
111
-0.5%
8,09
898 USD
|
111
-0.5%
|
8,09
|
898 USD
|
|
|
2022-01-07 |
2022-01-04 |
V
Vente
|
Barrett Elizabeth A.
Chief Executive Officer
Dirigeant
|
46 968
-13.6%
9,15
429 757 USD
|
46 968
-13.6%
|
9,15
|
429 757 USD
|
|
|
2021-12-02 |
2021-11-30 |
V
Vente
|
Smith Jason Drew
General Counsel
Dirigeant
|
3 803
-35.1%
12,03
45 750 USD
|
3 803
-35.1%
|
12,03
|
45 750 USD
|
|
|
2021-12-02 |
2021-11-30 |
V
Vente
|
Henderson Molly
Chief Financial Officer
Dirigeant
|
2 587
-34.5%
12,03
31 122 USD
|
2 587
-34.5%
|
12,03
|
31 122 USD
|
|
|
2021-11-19 |
2021-11-18 |
A
Achat
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
160
+0.7%
13,10
2 096 USD
|
160
+0.7%
|
13,10
|
2 096 USD
|
|
|
2021-11-02 |
2021-11-01 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
258
-1.2%
17,16
4 427 USD
|
258
-1.2%
|
17,16
|
4 427 USD
|
|
|
2021-10-28 |
2021-10-27 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
107
-0.5%
16,32
1 746 USD
|
107
-0.5%
|
16,32
|
1 746 USD
|
|
|
2021-05-18 |
2021-05-17 |
A
Achat
|
Smith Jason Drew
General Counsel
Dirigeant
|
2 500
+inf%
15,71
39 275 USD
|
2 500
+inf%
|
15,71
|
39 275 USD
|
|
|
2021-05-04 |
2021-04-30 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
243
-1.1%
20,00
4 860 USD
|
243
-1.1%
|
20,00
|
4 860 USD
|
|
|
2021-02-02 |
2021-01-31 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
1 076
-4.9%
22,07
23 747 USD
|
1 076
-4.9%
|
22,07
|
23 747 USD
|
|
|
2021-01-26 |
2021-01-26 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
100
-0.5%
22,12
2 212 USD
|
100
-0.5%
|
22,12
|
2 212 USD
|
|
|
2020-12-15 |
2020-12-14 |
A
Achat
|
Barrett Elizabeth A.
Chief Executive Officer
Dirigeant
|
10 000
+4.6%
18,50
185 000 USD
|
10 000
+4.6%
|
18,50
|
185 000 USD
|
|
|
2020-12-07 |
2020-12-04 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
662
-3.2%
19,85
13 141 USD
|
662
-3.2%
|
19,85
|
13 141 USD
|
|
|
2020-10-28 |
2020-10-26 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
101
-0.5%
20,95
2 116 USD
|
101
-0.5%
|
20,95
|
2 116 USD
|
|
|
2020-10-16 |
2020-10-15 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
1 017
-8.9%
21,72
22 089 USD
|
1 017
-8.9%
|
21,72
|
22 089 USD
|
|
|
2020-10-16 |
2020-10-15 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
407
-3.4%
21,82
8 882 USD
|
407
-3.4%
|
21,82
|
8 882 USD
|
|
|
2020-10-16 |
2020-10-15 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
976
-7.6%
21,80
21 276 USD
|
976
-7.6%
|
21,80
|
21 276 USD
|
|
|
2020-09-08 |
2020-09-04 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
348
-1.8%
20,20
7 030 USD
|
348
-1.8%
|
20,20
|
7 030 USD
|
|
|
2020-09-01 |
2020-09-01 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
509
-6.1%
22,82
11 615 USD
|
509
-6.1%
|
22,82
|
11 615 USD
|
|
|
2020-07-28 |
2020-07-27 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
70
-0.4%
23,51
1 646 USD
|
70
-0.4%
|
23,51
|
1 646 USD
|
|
|
2020-07-28 |
2020-07-27 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
141
-1.9%
23,51
3 315 USD
|
141
-1.9%
|
23,51
|
3 315 USD
|
|
|
2020-06-05 |
2020-06-04 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
349
-1.9%
27,51
9 602 USD
|
349
-1.9%
|
27,51
|
9 602 USD
|
|
|
2020-05-20 |
2020-05-20 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
358
-4.8%
25,07
8 975 USD
|
358
-4.8%
|
25,07
|
8 975 USD
|
|
|
2020-04-28 |
2020-04-27 |
V
Vente
|
Mullennix Stephen
Chief Operating Officer
Dirigeant
|
145
-1.4%
24,35
3 531 USD
|
145
-1.4%
|
24,35
|
3 531 USD
|
|
|
2020-04-28 |
2020-04-27 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
70
-0.4%
24,35
1 705 USD
|
70
-0.4%
|
24,35
|
1 705 USD
|
|
|
2020-04-28 |
2020-04-27 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
141
-2.2%
24,35
3 433 USD
|
141
-2.2%
|
24,35
|
3 433 USD
|
|
|
2020-02-24 |
2020-02-20 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
360
-5.6%
29,68
10 685 USD
|
360
-5.6%
|
29,68
|
10 685 USD
|
|
|
2020-02-18 |
2020-02-14 |
V
Vente
|
Mullennix Stephen
Chief Operating Officer
Dirigeant
|
612
-5.9%
28,04
17 160 USD
|
612
-5.9%
|
28,04
|
17 160 USD
|
|
|
2020-01-28 |
2020-01-27 |
V
Vente
|
Mullennix Stephen
Chief Operating Officer
|
684
-7.3%
29,26
20 014 USD
|
684
-7.3%
|
29,26
|
20 014 USD
|
|
|
2020-01-28 |
2020-01-27 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
|
322
-3.4%
29,15
9 386 USD
|
322
-3.4%
|
29,15
|
9 386 USD
|
|
|
2020-01-28 |
2020-01-27 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
|
667
-13.1%
29,28
19 530 USD
|
667
-13.1%
|
29,28
|
19 530 USD
|
|
|
2019-11-22 |
2019-11-21 |
A
Achat
|
Barrett Elizabeth A.
Chief Executive Officer
Dirigeant
|
7 530
+83.5%
28,00
210 840 USD
|
7 530
+83.5%
|
28,00
|
210 840 USD
|
|
|
2019-11-22 |
2019-11-20 |
A
Achat
|
Barrett Elizabeth A.
Chief Executive Officer
Dirigeant
|
7 470
+482.6%
28,00
209 160 USD
|
7 470
+482.6%
|
28,00
|
209 160 USD
|
|
|
2019-11-22 |
2019-11-20 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
354
-9.3%
28,41
10 057 USD
|
354
-9.3%
|
28,41
|
10 057 USD
|
|
|
2019-11-21 |
2019-11-19 |
A
Achat
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
1 960
+32.6%
28,17
55 213 USD
|
1 960
+32.6%
|
28,17
|
55 213 USD
|
|
|
2019-11-18 |
2019-11-15 |
A
Achat
|
Barrett Elizabeth A.
Chief Executive Officer
Dirigeant
|
1 548
+inf%
26,00
40 248 USD
|
1 548
+inf%
|
26,00
|
40 248 USD
|
|
|
2019-11-18 |
2019-11-14 |
V
Vente
|
Mullennix Stephen
Chief Operating Officer
Dirigeant
|
608
-7.3%
26,00
15 806 USD
|
608
-7.3%
|
26,00
|
15 806 USD
|
|
|
2019-09-06 |
2019-09-04 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
|
343
-5.4%
33,92
11 635 USD
|
343
-5.4%
|
33,92
|
11 635 USD
|
|
|
2019-08-22 |
2019-08-20 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
1 416
-34.0%
33,07
46 827 USD
|
1 416
-34.0%
|
33,07
|
46 827 USD
|
|
|
2019-08-16 |
2019-08-15 |
V
Vente
|
Mullennix Stephen
Chief Operating Officer
Dirigeant
|
608
-8.5%
31,65
19 243 USD
|
608
-8.5%
|
31,65
|
19 243 USD
|
|
|
2019-05-16 |
2019-05-14 |
V
Vente
|
Mullennix Stephen
Chief Operating Officer
|
608
-10.2%
37,98
23 092 USD
|
608
-10.2%
|
37,98
|
23 092 USD
|
|
|
2019-03-22 |
2019-03-21 |
A
Achat
|
Schoenberg Mark
Chief Medical Officer
|
272
+6.3%
37,01
10 066 USD
|
272
+6.3%
|
37,01
|
10 066 USD
|
|
|
2019-03-07 |
2019-03-06 |
V
Vente
|
Schoenberg Mark
Chief Medical Officer
Dirigeant
|
1 991
-31.5%
37,30
74 264 USD
|
1 991
-31.5%
|
37,30
|
74 264 USD
|
|
